Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
361.19M | 360.53M | 693.26M | 1.12B | 892.40M | 478.60M | Gross Profit |
198.75M | 194.78M | 385.66M | 649.77M | 495.83M | 212.80M | EBIT |
-193.97M | -223.35M | -38.22M | 180.24M | 65.25M | -97.22M | EBITDA |
-169.10M | -173.70M | 9.53M | 255.86M | 145.27M | -29.28M | Net Income Common Stockholders |
-222.60M | -245.20M | -73.15M | 125.04M | 41.97M | -98.59M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
102.77M | 118.58M | 187.29M | 205.88M | 130.57M | 148.90M | Total Assets |
855.28M | 864.64M | 1.08B | 1.18B | 1.05B | 1.02B | Total Debt |
148.81M | 149.36M | 157.75M | 155.60M | 330.79M | 384.45M | Net Debt |
46.04M | 30.79M | -29.54M | -31.75M | 200.22M | 235.55M | Total Liabilities |
362.11M | 348.36M | 393.99M | 503.64M | 561.19M | 631.33M | Stockholders Equity |
493.18M | 516.28M | 686.26M | 676.38M | 489.20M | 391.12M |
Cash Flow | Free Cash Flow | ||||
-88.58M | -68.74M | 23.56M | 336.29M | 121.48M | 58.31M | Operating Cash Flow |
-72.67M | -45.30M | 43.37M | 388.73M | 168.23M | 73.59M | Investing Cash Flow |
-16.73M | -23.45M | -15.94M | -91.76M | -91.76M | -175.29M | Financing Cash Flow |
1.25M | 1.29M | -26.36M | -240.40M | -91.90M | 159.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $694.36M | 19.61 | 4.72% | 5.77% | -0.41% | -46.38% | |
63 Neutral | $704.72M | ― | -2.55% | ― | 3.57% | -134.36% | |
62 Neutral | $11.97B | 10.29 | -7.47% | 2.99% | 7.32% | -8.06% | |
60 Neutral | $830.54M | ― | -9.87% | ― | -30.75% | -3668.44% | |
58 Neutral | $929.62M | 33.33 | 3.30% | ― | 20.20% | ― | |
57 Neutral | $610.06M | ― | -2.35% | ― | 13.41% | 72.56% | |
49 Neutral | $1.05B | ― | -39.36% | ― | -33.12% | -39.38% |
MaxLinear held its 2025 Annual Meeting of Stockholders on May 20, 2025, where several key decisions were made. Daniel A. Artusi was re-elected as a Class I director, while the proposed executive officer compensation and amendment to the 2010 Equity Incentive Plan were not approved by stockholders. The appointment of Grant Thornton LLP as the independent registered public accounting firm for 2025 was ratified.
The most recent analyst rating on (MXL) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Maxlinear stock, see the MXL Stock Forecast page.